Sinovac Biotech SVA
NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 28, 2026 · 4:00 PM EDT

Sinovac Biotech (SVA) Liabilities from Discontinued Operations (2014 - 2017)

Updated

Sinovac Biotech (SVA) recorded Liabilities from Discontinued Operations of $118,000 in Q2 2017.

Analysis

Sinovac Biotech (SVA) Liabilities from Discontinued Operations (2014 - 2017) Analysis & Trends

At the end of FY2016, Sinovac Biotech reported Liabilities from Discontinued Operations of $89,000, down 63.4% from FY2015.

  • Across earlier years, Liabilities from Discontinued Operations came in at $243,000 in FY2015 (-66.6%) and $727,000 in FY2014.
  • The Q2 2017 figure is the highest quarterly Liabilities from Discontinued Operations since Q4 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Sinovac Biotech 464.94 Mn -24.98 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 118,000.00
Dec 31, 2016 89,000.00
Dec 31, 2015 243,000.00
Dec 31, 2014 727,000.00
API Access

Sinovac Biotech Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=SVA&period=max&api_key=YOUR_API_KEY